| P50 | author | Ian Mitchelle S De Vera | Q57022947 |
| | Jinsai Shang | Q58669646 |
| | Travis S Hughes | Q60988528 |
| | Douglas J Kojetin | Q88295548 |
| | Yanan Long | Q88574233 |
| | Rodrigo Galindo-Murillo | Q88574234 |
| P2093 | author name string | Patrick R Griffin | |
| | Theodore M Kamenecka | |
| | Zahra Heidari | |
| | Thomas E Cheatham | |
| | Anne-Laure Blayo | |
| | Youseung Shin | |
| | Hermes Reyes-Caballero | |
| | Jakob Fuhrmann | |
| | Michelle D Nemetchek | |
| | Ian M Chrisman | |
| P2860 | cites work | Comparison of simple potential functions for simulating liquid water | Q26778447 |
| | Review of the Structural and Dynamic Mechanisms of PPARγ Partial Agonism | Q26782232 |
| | Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha | Q27637763 |
| | Partial agonists activate PPARgamma using a helix 12 independent mechanism | Q27648786 |
| | Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) γ Activators and Pan-PPAR Partial Agonists | Q27679376 |
| | Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha | Q27730245 |
| | Molecular basis of agonism and antagonism in the oestrogen receptor | Q27746278 |
| | Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma | Q27765353 |
| | The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen | Q27766417 |
| | AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading | Q27860652 |
| | UCSF Chimera--a visualization system for exploratory research and analysis | Q27860666 |
| | Comparative protein modelling by satisfaction of spatial restraints | Q27860866 |
| | How many drug targets are there? | Q28276660 |
| | A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat | Q28368216 |
| | Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes | Q29397708 |
| | Development and testing of a general amber force field | Q29547642 |
| | An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) | Q29615693 |
| | Dynamic personalities of proteins | Q29616723 |
| | 19F NMR studies of solvent exposure and peptide binding to an SH3 domain | Q30159515 |
| | Tryptophan solvent exposure in folded and unfolded states of an SH3 domain by 19F and 1H NMR. | Q30159555 |
| | (19)F-modified proteins and (19)F-containing ligands as tools in solution NMR studies of protein interactions. | Q30381481 |
| | Current applications of 19F NMR to studies of protein structure and dynamics | Q30413506 |
| | R.E.D. Server: a web service for deriving RESP and ESP charges and building force field libraries for new molecules and molecular fragments | Q31014950 |
| | PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data | Q31026348 |
| | Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate | Q31033935 |
| | Simulations of NMR pulse sequences during equilibrium and non-equilibrium chemical exchange. | Q52071939 |
| | Conformational Diversity of the Helix 12 of the Ligand Binding Domain of PPARγ and Functional Implications. | Q53189489 |
| | Modeling Loops in Protein Structures | Q58046189 |
| | Activation of the A2A adenosine G-protein-coupled receptor by conformational selection | Q59070946 |
| | Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation | Q73675477 |
| | Mechanistic elucidation guided by covalent inhibitors for the development of anti-diabetic PPARγ ligands | Q90403601 |
| | Binding of ligands and activation of transcription by nuclear receptors. | Q34243256 |
| | Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. | Q34330155 |
| | Helix 11 dynamics is critical for constitutive androstane receptor activity. | Q34548544 |
| | DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex | Q34927801 |
| | Molecular determinants of nuclear receptor-corepressor interaction | Q35210593 |
| | Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer | Q35587470 |
| | Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling | Q35638953 |
| | Deconvolution of Complex 1D NMR Spectra Using Objective Model Selection | Q35737665 |
| | Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism. | Q35753031 |
| | Pharmacological repression of PPARγ promotes osteogenesis | Q35754510 |
| | Mechanism of the nuclear receptor molecular switch | Q35846738 |
| | Structural mechanism for signal transduction in RXR nuclear receptor heterodimers. | Q35990304 |
| | Ligand control of coregulator recruitment to nuclear receptors | Q36041022 |
| | H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations | Q36088442 |
| | Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discovery | Q36497819 |
| | The dynamic process of β(2)-adrenergic receptor activation | Q36651876 |
| | Nuclear receptor structure: implications for function | Q36669652 |
| | ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. | Q36766916 |
| | Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis | Q36960979 |
| | Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation | Q37127495 |
| | The role of ligands on the equilibria between functional states of a G protein-coupled receptor | Q37149545 |
| | Colloidal drug formulations can explain "bell-shaped" concentration-response curves | Q37701412 |
| | Modification of the Orthosteric PPARγ Covalent Antagonist Scaffold Yields an Improved Dual-Site Allosteric Inhibitor. | Q38433439 |
| | An alternate binding site for PPARγ ligands | Q38449883 |
| | T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities | Q40747044 |
| | Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR. | Q41775482 |
| | Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations | Q41930764 |
| | Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator | Q42805803 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1794 | |
| P577 | publication date | 2018-05-04 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | Defining a conformational ensemble that directs activation of PPARγ | |
| P478 | volume | 9 | |